Pablo Legorreta, Royalty Pharma CEO (Patrick T. Fallon/Bloomberg via Getty Images)
Royalty Pharma tops its record-setting $3.3B deal with CF Foundation, betting $575M more on Vertex's drugs
Royalty Pharma’s $3.3 billion deal with the Cystic Fibrosis Foundation to purchase royalties on Vertex’s CF franchise was its largest royalty deal ever. But that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.